Abcam news

Jul-2020	Cancer Research UK and Abcam launch custom partnership to accelerate cancer research
Mar-2020	Abcam triumphs with industry award for knockout antibody validation success
Jan-2020	Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell’s Gene Editing Platform and Oncology Product Portfolio
Jan-2020	Abcam’s new CRISPR-Cas9 cell lines for target identification, validation and pathway discovery
Jan-2020	New JBC manuscript promotes industry-leading best practice guidance on antibody validation via Western blotting
Jan-2020	Abcam appoints Michael Baldock as Chief Financial Officer
Jan-2020	Abcam announces successful acquisition of Expedeon’s Proteomics and Immunology business, enhancing its conjugation capability
Dec-2019	Abcam and SomaServe announce comprehensive partnership to realise the potential of PolyNaut® ‘bionic’ nanoparticles for delivery to live cells
Dec-2019	Abcam Honoured As One Of The UK’s Best Places To Work In 2020; A Glassdoor Employees’ Choice Award Winner
Nov-2019	Abcam delivers outstanding performance in new Biocompare antibody market report
Nov-2019	Scientists poised to unlock their understanding of autophagy with new antibody-based insights
Nov-2019	Abcam agrees to acquire Expedeon’s Proteomics and Immunology business, expanding offerings into the fast-growing conjugation segment
Nov-2019	Abcam and BrickBio announce a partnership to incorporate conjugation-ready sites into recombinant antibodies across Abcam's portfolio
Nov-2019	Engineered knockout cell lysates for reproducible proteomic analysis
Jul-2019	Abcam Enters Cell Editing Market Through Acquisition of EdiGene’s Knock-out Cell Lines and Lysates Portfolio
May-2019	New tissue clearing kits and reagents for faster, accurate 3D imaging
Apr-2019	NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler
Mar-2019	Abcam collaborates with Visikol to develop new tools for improved tissue clearing and 3D imaging
Mar-2019	Abcam wins the UK-China Business award
Feb-2019	Abcam moves to new purpose-built global headquarters
Feb-2019	Dr Michael Weiner wins CiteAb’s 2019 Lifetime achievement award
Jan-2019	Abcam expands custom services capabilities with the acquisition of Calico Biolabs
Jan-2019	Abcam and the LouLou Foundation partner to develop key research tools for CDKL5 deficiency disorder
Dec-2018	QIAGEN (Suzhou) and Abcam sign strategic MoU collaboration agreement to co-develop companion diagnostic (CDx) and in vitro diagnostic (IVD) reagents and kits for the Chinese market
Dec-2018	Abcam 'Most Admired Company' award
Oct-2018	Abcam appoints Cheri Walker, PhD, as Senior Vice President, Corporate Development
Oct-2018	New PBS-only antibodies enable more flexible research
Jul-2018	Abcam Merck collaboration produces new PD-L1 antibody for immuno-oncology research
Jun-2018	Congratulations to Alan Hirzel, winner of European Mediscience Awards Chief Executive of the year award
Apr-2018	Abcam and Shuwen Biotech sign strategic MoU to establish global alliance for companion diagnostic (CDx) kit development
Feb-2018	New CatchPoint® SimpleStep® ELISA fluorescent 90-minute assay
Feb-2018	Introducing FirePlex®-HT High-throughput Multiplex Immunoassays – Delivering More Data from Precious Samples
Feb-2018	Abcam and Molecular Devices announce strategic collaboration
Jan-2018	Abcam wins another CiteAb award
Jan-2018	Abcam signs exclusive license agreement with Roche
Aug-2017	Abcam and TTP Labtech collaborate to develop sol-R reagent kits
Jul-2017	The University of Bath enters licensing agreement with Abcam to develop fluorescent detection probe kit for sugar-damaged proteins
Jun-2017	Abcam announces first international Epigenetics conference in South Korea
Jan-2017	Abcam wins two CiteAb awards
Nov-2016	Abcam wins Best Careers Website at the In-house Recruitment Awards
Jul-2016	New multiplex immunoassays with Firefly® particle technology
Apr-2016	Abcam enables faster drug and biomarker discovery with immunoassay research suite
Feb-2016	Congratulations to Jonathan Milner, winner of CiteAb’s Lifetime achievement award
Nov-2015	Abcam offers direct service to Singapore as part of deepening commitment to Asia-Pacific researchers
Nov-2015	Abcam acquires AxioMx to access new growth opportunities and extend antibody leadership
Oct-2015	Abcam’s new anti-PD-L1 antibody enables deeper insights into cancer immunology research
Sep-2015	Abcam raises antibody validation standards to improve quality for life science researchers
Jun-2015	Appointment of Chief Legal Officer and Company Secretary
Jun-2015	Abcam launches multiplex miRNA profiling assays
Jan-2015	Abcam signs exclusive partnership agreement with A*STAR's Institute of Molecular and Cell Biology
Dec-2014	Sue Harris appointed as non-Executive Director on Abcam Board
Dec-2014	Abcam appoints Yvonne Chien as Chief Digital Officer
Nov-2014	Abcam wins 'Best Use of Digital Media' at Life Science Industry Awards
Sep-2014	Abcam licenses novel Ceefourin inhibitors of multidrug resistance protein 4 from Australia's Children's Cancer Institute
Sep-2014	Abcam plc announces appointment of new CEO and Board changes
Sep-2014	Abcam and Cell Marque sign global strategic marketing agreement for IVD IHC RabMAb® antibodies
Sep-2014	Abcam introduces exclusive range of highly validated antibody conjugates
Jun-2014	Abcam's CEO wins Mediscience award
Mar-2014	Abcam introduces Alexa Fluor® 680/790 secondary antibodies for fluorescent western blotting
Feb-2014	Abcam Announces Winner of 15 Discoveries Contest
Jan-2014	Abcam to open office in Shanghai, China
Dec-2013	Abcam wins 'Most Admired Company' award
Nov-2013	Abcam Introduces Alexa Fluor Secondary Antibodies
Oct-2013	Abcam Named AIM Company of the Year
Sep-2013	Abcam Launches SimpleStep ELISA Kits
Jun-2013	Abcam appoints Alan Hirzel as Chief Marketing Officer
Apr-2013	Abcam Welcomes Students from Cambridge Regional College
Mar-2013	Abcam donates an additional £45,000 to local charities
Dec-2012	Abcam helps contribute to growth of hi-tech sector in Cambridge, UK
Nov-2012	We have reached 100,000 products
Oct-2012	HRH The Duke of York visits Abcam to see the Cambridge Phenomenon in action
Sep-2012	Rabbit monoclonal antibodies, available from Abcam following acquisition of Epitomics
Jan-2012	New range of Biochemicals now available from Abcam
Sep-2011	Abcam acquires Ascent Scientific, a specialist provider of biochemicals
May-2011	Abcam acquires MitoSciences in deal which enhances immunoassay portfolio
Nov-2010	Jonathan Milner wins Entrepreneur of the Year award.
Jul-2010	Abcam's Jonathan Milner wins CEO of the Year
Jul-2010	300th employee hired
Mar-2010	Abcam wins 'Business of the Year 2009' at the Business Weekly East of England Awards.
Feb-2010	Abcam founder wins 'CEO of the Year' at Quoted Company Awards 2010
Jan-2010	Abcam and Cambridge Design Partnership develop innovative labeling solution
Oct-2009	Abcam named 'Company of the Year' at 2009 AIM Awards
Jun-2009	Abcam’s expansion continues with its fourth move on the Cambridge Science Park
Nov-2008	Winners of tenth anniversary competition announced
Jul-2008	200th employee hired
May-2008	Licensing deal signed with Tepnel Life Sciences
Mar-2008	Grand setting for Japanese sub-dealer meetings
Nov-2007	Automated system to expand monoclonal production
Nov-2007	Abcam and leading antibody producer collaborate to make 12,000 rabbit polyclonals
Nov-2007	CLC bio customized software supports Abcam's monoclonal development capability
Nov-2007	Jeffrey Iliffe appointed as Chief Financial Officer
May-2007	Same day delivery in Cambridge UK
Mar-2007	Over 30,000 products in our catalog
Mar-2007	Abcam to partner in the EPITRON project
Jan-2007	$2 to Médecins Sans Frontières for every new registration
Jul-2006	Extra Abpoints introduced for first Abreviews
Jul-2006	Appointment of Non-Executive Directors
Jun-2006	Winner of Best Newcomer in the European Mediscience awards
May-2006	Better antibodies, faster
Feb-2006	Winner of Private Company of the Year, Business Weekly East of England Business Awards 2005
Feb-2006	20,000+ products, 1,300 new lysates, Abpromise stats, Abupdate & news
Jan-2006	Fast Abpromise support, free loading control samples, Abupdate & news
Nov-2005	Search filter, conjugated loading controls, Abupdate & news
Sep-2005	Top forty position, Sunday Times Microsoft Tech Track
May-2005	US office on the move
Apr-2005	Queen's Award at first attempt
Apr-2005	More space
Dec-2004	A faster service
Oct-2004	First place in Deloitte's Fast 50
Sep-2004	50th employee hired
Sep-2004	Top forty position, Sunday Times Microsoft Tech Track
Jun-2004	Jim Warwick becomes Managing Director (Abcam Ltd)
Feb-2004	Collaboration deal struck with Purely Proteins
Jan-2004	A New Year's Honour
Dec-2003	High growth status recognised again, this time nationally
Oct-2003	Success in Deloitte's Regional Technology Fast 50
Sep-2003	Top twenty position, Sunday Times Arm Tech Track
Jul-2003	British royalty visits Abcam
May-2003	First overseas office established
Apr-2003	Jim Warwick (Technical Director) becomes full-time
Mar-2003	CEN Business Excellence Awards winner
Mar-2003	25th employee hired
Feb-2003	On the move again
Nov-2002	Deloitte Top 50 regional winner
Aug-2002	FedEx tie-up boosts customer support services
Jun-2001	Technical Director appointed
May-2001	UK Online for Business Award, highly commended
Oct-2000	CEN Millennium Business Excellence Awards finalist
May-2000	10th employee hired
Apr-2000	Finance Director appointed
Mar-2000	New premises on the Cambridge Science Park
Oct-1999	First (of many) awards
Oct-1998	Open for business

技術情報や製品情報をメールで受け取る登録